Has Ammar Killu received payments from drug or device companies?

Yes. Drug and device makers reported $138,673 in general payments to Ammar Killu across 174 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ammar Killu did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ammar Killu come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ammar Killu

Cardiovascular Disease · Rochester, MNNPI 1790006658

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $83,364 of the $138,673 with a category attached, or 60.1%. 7 manufacturers reported payments, led by Atricure, Inc. at 32.9% of the total. 2025 is the largest year on record at $71,300, 7.3 times the $9,732 reported in 2019. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$138,673in general payments, 2019–2025

Across 174 payments — averaging $796.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$46K
Abbott$43K
Boston Scientific$34K
Medical Device Business Services, Inc.$9K
Biosense Webster, Inc.$4K
Siemens Medical Solutions USA, Inc.$3K
plus $557 from 1 others

$404,274in research payments, 2019–2025

Across 101 payments — averaging $4002.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$273K
Atricure, Inc.$91K
Biosense Webster, Inc.$21K
Abbott$19K

What the payments were for

Consulting fees$83,36460%
Speaking & faculty fees$5,3434%
Travel & lodging$43,00331%
Food & beverage$6,9345%
Education$300%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	76	$45,666
Abbott	26	$43,024
Boston Scientific	37	$33,719
Medical Device Business Services, Inc.	13	$8,807
Biosense Webster, Inc.	14	$4,323
Siemens Medical Solutions USA, Inc.	2	$2,577
Medtronic	6	$557

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$31,109
TACTICATH ABLATION CATHETER, SENSOR ENABLED$27,371
Farapulse$24,246
ENSITE$11,263
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$8,445
SYNERGY ABLATION SYSTEM$8,182
Carto 3$6,715
Carto 3 System$4,163
WATCHMAN Access System$3,750
ENSITE PRECISION$2,963
ACUSON Origin Diagnostic Ultrasound System$2,577
EPI-SENSE GUIDED COAGULATION SYS$2,136
WATCHMAN FLX$1,875
Watchman$1,168
ATRICLIP LAA EXCLUSION SYSTEM$1,147
Thermocool$913
AMPLATZER AMULET$816
Thermocool SF$733
ATRICURE CRYOSURGICAL SYSTEM$720
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$671

How this compares

$138,673 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.

See all cardiovascular disease providers in Minnesota →

Medicare billing

Part B allowed, 2024

$119,352

Medicare patients

975

Services billed

1,805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	27	$32,767
Dofetilide	12	$6,934
Amiodarone Hcl	17	$733
Metoprolol Succinate	17	$436

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Rochester

Srijoy MahapatraRochester$1.2M
Charanjit RihalRochester$478K
Amir LermanRochester$465K
Martha GroganRochester$330K
Virend SomersRochester$262K
Francisco Lopez-JimenezRochester$167K
Allan JaffeRochester$111K
Robert McBaneRochester$110K
Michael McGoonRochester$106K
R Scott WrightRochester$95K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →